甘氨酸
新陈代谢
氨基酸
肥胖
生物化学
生物
生理学
内分泌学
化学
医学
作者
Anaïs Alves,Arthur Bassot,Anne‐Laure Bulteau,Luciano Pirola,Béatrice Morio
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2019-06-16
卷期号:11 (6): 1356-1356
被引量:263
摘要
Glycine is the proteinogenic amino-acid of lowest molecular weight, harboring a hydrogen atom as a side-chain. In addition to being a building-block for proteins, glycine is also required for multiple metabolic pathways, such as glutathione synthesis and regulation of one-carbon metabolism. Although generally viewed as a non-essential amino-acid, because it can be endogenously synthesized to a certain extent, glycine has also been suggested as a conditionally essential amino acid. In metabolic disorders associated with obesity, type 2 diabetes (T2DM), and non-alcoholic fatty liver disease (NAFLDs), lower circulating glycine levels have been consistently observed, and clinical studies suggest the existence of beneficial effects induced by glycine supplementation. The present review aims at synthesizing the recent advances in glycine metabolism, pinpointing its main metabolic pathways, identifying the causes leading to glycine deficiency—especially in obesity and associated metabolic disorders—and evaluating the potential benefits of increasing glycine availability to curb the progression of obesity and obesity-related metabolic disturbances. This study focuses on the importance of diet, gut microbiota, and liver metabolism in determining glycine availability in obesity and associated metabolic disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI